36 reports

Brain Cancer - Epidemiology Forecast to 2030 Summary Primary brain cancer (ICD-10 = C70, C71, C72) is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem (National Cancer Institute, 2021).The...

  • Brain Cancer
  • Epidemiology
  • China
  • Japan
  • United States
  • World
  • Cancer Incidence
  • Urban Population

The brain cancer diagnostics market was valued at US$ 844.63 million in 2021 and is projected to reach US$ 2,476.14 million by 2028; it is expected to grow at a CAGR of 16.6 % from 2021 to 2028. The growth of the brain cancer diagnostics market is attributed to factors such as an increase in the prevalence of brain cancer worldwide...

  • Brain Cancer
  • Diagnostics
  • World
  • APAC
  • Middle East
  • Central America
  • Smoking Prevalence
  • Health Expenditure

China’s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Brain Cancer
  • China
  • Industrial Production
  • Labour Force

Brain Cancer (Oncology) - Drugs in Development, 2021 Summary Brain Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Brain Cancer, complete with...

  • Brain Cancer
  • World

Midkine - Pipeline Review, H1 2020 Summary Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Midkine (MDK) or neurite growth-promoting factor 2 is a protein encoded by the MDK gene. It binds to anaplastic lymphoma kinase...

  • Lung Cancer
  • Brain Cancer
  • Chronic Disease
  • Biopharmaceutical
  • World
  • Europe

Global Brain Tumor Diagnostics Market 2022-2026 The analyst has been monitoring the brain tumor diagnostics market and it is poised to grow by $ 177.66 mn during 2022-2026, progressing at a CAGR of 3.89% during the forecast period. Our report on the brain tumor diagnostics market provides a holistic analysis, market size...

  • Brain Cancer
  • Diagnostics
  • World

Global Brain Tumor Therapeutics Market 2021-2025 The analyst has been monitoring the brain tumor therapeutics market and it is poised to grow by $ 1.23 billion during 2021-2025, progressing at a CAGR of 9.67% during the forecast period. Our report on the brain tumor therapeutics market provides a holistic analysis, market...

  • Brain Cancer
  • Therapy
  • World

Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End Use, By Region, And Segment Forecasts, 2021 - 2028 Glioblastoma Multiforme Treatment Market Growth & Trends The global glioblastoma multiforme treatment...

  • Therapy
  • Brain Cancer
  • World
  • APAC
  • North America
  • United Kingdom

Midkine - Pipeline Review, H2 2019 Summary Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining...

  • Lung Cancer
  • Brain Cancer
  • Chronic Disease
  • Biopharmaceutical
  • World
  • Europe

The global glioblastoma multiforme treatment market exhibited strong growth during 2015-2020. Glioblastoma multiforme, also known as grade IV astrocytoma, is a malignant grade IV brain tumor that rapidly spreads within the brain cells and can also infect the nearby cells. Since it is characterized by rapid cell degeneration,...

  • Brain Cancer
  • World

Major players in the brain tumor drugs market are Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., AstraZeneca, Carestream Health, Philips Healthcare, Siemens Healthineers, Hitachi Medical Corporation and GE Healthcare. The global brain tumor drugs market is expected to grow from $3.17 billion in 2021 to...

  • Brain Cancer
  • Cancer
  • World
  • United States
  • Middle East
  • APAC
  • Life Expectancy

This study focuses on China’s Brain Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Brain Cancer
  • China
  • Employment Costs
  • Prescription Drug Sales

This study focuses on China’s Brain Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Brain Cancer
  • China
  • Labour Force
  • Industrial Production

“Glioblastoma - Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Cancer
  • Brain Cancer
  • Therapy
  • World
  • Energy Supply

Summary MagForce AG (MagForce) is a medical device manufacturing company.The company is engaged in the development of nanotechnology-based therapy for the treatment of cancer. It’s products portfolio include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy.The NanoActivator creates a magnetic field that...

  • Cancer
  • Brain Cancer
  • Clinical Trial
  • Europe
  • Germany
  • Poland
  • World
  • Western Europe
  • Medical Devices Sales

The ongoing clinical trial research report- “2019 Brain Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Brain Cancer trials across the world. The report presents top level analysis of global Brain Cancer clinical trials across countries, companies and universities. It is designed to provide clear understanding...

  • Brain Cancer
  • Clinical Trial
  • World
  • APAC

The North America Cranial Implants Market would witness market growth of 5.5% CAGR during the forecast period (2019-2025). Cranial reconstruction or cranioplasty is an operation used to reconstruct skeletal flaws or deformities inflicted by ischemic, traumatic brain injury (TBI), hemorrhagic, or brain cancer. Using cranial implants,...

  • Thermoplastic
  • Neurological Disorder
  • Synthetic Resin
  • Neurology
  • Petrochemical Intermediates
  • Marketing Research
  • Brain Cancer
  • North America
  • United States

Report Scope: This report provides an overview of the current and future global market potential for brain tumor therapeutics. It provides a detailed analysis and information about conventional treatment options, ongoing market trends and the future direction of the market with respect to brain tumor therapy. Inclusions -...

  • Brain Cancer
  • Therapy
  • World
  • Mortality Rate

Glioblastoma Multiforme - Global Drug Forecast and Market Analysis to 2030 Summary Glioblastoma multiforme (GBM) is now defined by the WHO 2021 as a diffuse astrocytic glioma with no mutations in IDH genes or histone H3 genes.It is the most common primary brain tumor in humans. Like other...

  • Brain Cancer
  • World
  • Cancer Incidence
  • Drug Approval

About Brain Cancer Imaging Brain cancer imaging is a diagnostic screening method that helps medical professionals to analyze the activity and function of the brain and determine the presence of any cancerous cells in the brain. Several types of brain cancer imaging modalities are available in the market that offer brain...

  • Brain Cancer
  • World

Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H1 2018 Summary According to the recently published report ’Midkine - Pipeline Review, H1 2018’; Midkine (Amphiregulin Associated Protein or Midgestation...

  • Lung Cancer
  • Brain Cancer
  • World
  • United Kingdom

Summary University of North Carolina (UNC) is an educational service provider which offers various academic courses and research services.The university provides academic programs such as academic program inventory, distance education inventory, academic common market, certificate inventory, UNC online, professional science...

  • Therapy
  • Cancer
  • Healthcare
  • Gene Therapy
  • Pharmaceutical
  • Brain Cancer
  • Medicine Use
  • Mortality Rate

Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients.The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and prevention, structural and...

  • Cancer
  • Oncology
  • Brain Cancer
  • Pharmaceutical
  • Healthcare
  • Europe
  • Colorectal Cancer Screening Coverage
  • Health Provider Density

Summary Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials.The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its...

  • Therapy
  • Cancer
  • Pathology
  • Pharmaceutical
  • Brain Cancer
  • Infectious Disease
  • Healthcare
  • Fuel Production
  • Diagnostic Imaging Density

Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology.The company’s pipeline products include PAT-SC1 an immunoglobulin M (IgM) type antibody used for the treatment of gastric cancer; PAT-SM6 is a fully human monoclonal antibody...

  • Brain Cancer
  • Pharmaceutical
  • Healthcare
  • Australia
  • Paid Claims
  • Capital Flows

Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027 Summary The Glioblastoma Multiforme (GBM) market is expected to grow from $662.0m in 2017 to $1.4bn in 2027 across the eight major markets (8MM) ( US, France, Germany, Italy, Spain, UK, Japan, and urban China) representing...

  • Brain Cancer
  • World
  • Cancer Incidence
  • Drug Approval

E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2018 Summary According to the recently published report ’E3 Ubiquitin Protein...

  • Cancer
  • Lung Cancer
  • Hospital
  • Oncology
  • Brain Cancer
  • Clinical Trial
  • Pharmaceutical
  • World
  • Australia
  • Pharmaceutical Registrations
  • Prescription Drug Sales

Summary Northwestern University is an educational service provider that offers graduate professional and undergraduate educational programs.The university offers graduate and professional programs which include communication, education and social policy, engineering and applied sciences, journalism, media, integrated marketing...

  • Therapy
  • Cancer
  • Specialty Hospital
  • Healthcare
  • Brain Cancer
  • Medical Technology Density
  • Drug Approval

Neuroendoscopy Devices Market Analysis Report By Surgery (Intraventricular, Transcranial, Transnasal), By Device Type (Rigid, Flexible), By Application, And Segment Forecasts, 2018 - 2025 The global neuroendoscopy devices market is expected to reach USD 203.9 million by 2025, according to a new report by Grand View Research, Inc. Demand...

  • Endoscopic Device
  • Brain Cancer
  • Cancer
  • Endoscope
  • World

Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Pipeline Review, H2 2017 Summary Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Midkine (MDK) or neurite growth-promoting...

  • Lung Cancer
  • Brain Cancer
  • World
  • United Kingdom